tiprankstipranks
Teladoc (MX:TDOC)
:TDOC
Mexico Market

Teladoc (TDOC) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

TDOC Analyst Ratings

Hold
16Ratings
Hold
4 Buy
12 Hold
0 Sell
Based on 16 analysts giving stock ratings to
Teladoc
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TDOC Stock 12 Month Forecast

Average Price Target

$130.20
▲(23.78% Upside)
Based on 16 Wall Street analysts offering 12 month price targets for Teladoc in the last 3 months. The average price target is $130.20 with a high forecast of $178.32 and a low forecast of $93.40. The average price target represents a 23.78% change from the last price of $105.19.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"88":"$88","179":"$179","110.75":"$110.8","133.5":"$133.5","156.25":"$156.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":178.316690475,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$178.32</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":130.19948828333335,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$130.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":93.403980725,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$93.40</span>\n  </div></div>","useHTML":true}}],"tickPositions":[88,110.75,133.5,156.25,179],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,107.4,112.85513003653847,118.31026007307693,123.7653901096154,129.22052014615386,134.67565018269232,140.13078021923076,145.58591025576925,151.04104029230768,156.49617032884618,161.9513003653846,167.40643040192307,172.86156043846154,{"y":178.316690475,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,107.4,109.15380679102564,110.90761358205128,112.66142037307694,114.41522716410257,116.16903395512821,117.92284074615385,119.6766475371795,121.43045432820514,123.18426111923078,124.93806791025642,126.69187470128207,128.4456814923077,{"y":130.19948828333335,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,107.4,106.32338313269231,105.24676626538462,104.17014939807693,103.09353253076924,102.01691566346155,100.94029879615385,99.86368192884615,98.78706506153846,97.71044819423076,96.63383132692307,95.55721445961538,94.48059759230769,{"y":93.403980725,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":144.57,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":141,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":162.6,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":135.69,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.7,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":94,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.77,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":91.79,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":107,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":135.44,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":116,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":107.4,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$178.32Average Price Target$130.20Lowest Price Target$93.40
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on MX:TDOC
Truist Financial
Truist Financial
Hold
Reiterated
09/01/26
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (NASDAQ: VRDN), Teladoc (NYSE: TDOC) and Protagonist Therapeutics (NASDAQ: PTGX)
Bank of America Securities Analyst forecast on MX:TDOC
Bank of America Securities
Bank of America Securities
$178.32
Buy
69.52%
Upside
Reiterated
08/31/26
Analyst Maintains Buy Rating on Teladoc with Unchanged $10.50 Price Target Amid Strategic Transition and New CFO Appointment
Canaccord Genuity Analyst forecast on MX:TDOC
Canaccord Genuity
Canaccord Genuity
$169.83
Buy
61.45%
Upside
Reiterated
08/31/26
Teladoc Buy Rating Reaffirmed as New CFO Appointment Stabilizes Leadership; $10 Price Target Maintained
Oppenheimer
$118.88
Buy
13.01%
Upside
Assigned
08/04/26
Analysts Are Bullish on These Healthcare Stocks: Senseonics Holdings (SENS), Teladoc (TDOC)
Barclays
$118.88
Hold
13.01%
Upside
Reiterated
08/03/26
Barclays Sticks to Their Hold Rating for Teladoc (TDOC)
TD Cowen
$101.9
Hold
-3.13%
Downside
Reiterated
08/03/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Teladoc (NYSE: TDOC) and Karyopharm Therapeutics (NASDAQ: KPTI)
Citi
$186.81$127.37
Hold
21.08%
Upside
Reiterated
08/03/26
Teladoc price target lowered to $7.50 from $11 at CitiTeladoc price target lowered to $7.50 from $11 at Citi
Jefferies
$152.84$135.86
Hold
29.16%
Upside
Reiterated
07/30/26
Teladoc price target lowered to $8 from $9 at JefferiesTeladoc price target lowered to $8 from $9 at Jefferies
Stifel Nicolaus Analyst forecast on MX:TDOC
Stifel Nicolaus
Stifel Nicolaus
$93.4
Hold
-11.20%
Downside
Reiterated
07/30/26
Teladoc (TDOC) Receives a Hold from Stifel Nicolaus
Evercore ISI
$169.83$127.37
Hold
21.08%
Upside
Reiterated
07/30/26
Teladoc price target lowered to $7.50 from $10 at Evercore ISITeladoc price target lowered to $7.50 from $10 at Evercore ISI
Wells Fargo Analyst forecast on MX:TDOC
Wells Fargo
Wells Fargo
$101.9
Hold
-3.13%
Downside
Reiterated
07/30/26
Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC) and GE Healthcare Technologies Inc (NASDAQ: GEHC)
Needham
Hold
Reiterated
07/30/26
Teladoc: Mixed Business Performance and BetterHelp Growth Uncertainty Keep Ryan MacDonald at Hold
Cantor Fitzgerald Analyst forecast on MX:TDOC
Cantor Fitzgerald
Cantor Fitzgerald
$169.83
Buy
61.45%
Upside
Reiterated
07/29/26
Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), Teladoc (TDOC)
William Blair Analyst forecast on MX:TDOC
William Blair
William Blair
Hold
Reiterated
07/29/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Teladoc (NYSE: TDOC) and Boston Scientific (NYSE: BSX)
BMO Capital Analyst forecast on MX:TDOC
BMO Capital
BMO Capital
$84.91$118.88
Hold
13.01%
Upside
Assigned
07/29/26
Teladoc (TDOC) Receives a Hold from BMO Capital
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on MX:TDOC
Truist Financial
Truist Financial
Hold
Reiterated
09/01/26
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (NASDAQ: VRDN), Teladoc (NYSE: TDOC) and Protagonist Therapeutics (NASDAQ: PTGX)
Bank of America Securities Analyst forecast on MX:TDOC
Bank of America Securities
Bank of America Securities
$178.32
Buy
69.52%
Upside
Reiterated
08/31/26
Analyst Maintains Buy Rating on Teladoc with Unchanged $10.50 Price Target Amid Strategic Transition and New CFO Appointment
Canaccord Genuity Analyst forecast on MX:TDOC
Canaccord Genuity
Canaccord Genuity
$169.83
Buy
61.45%
Upside
Reiterated
08/31/26
Teladoc Buy Rating Reaffirmed as New CFO Appointment Stabilizes Leadership; $10 Price Target Maintained
Oppenheimer
$118.88
Buy
13.01%
Upside
Assigned
08/04/26
Analysts Are Bullish on These Healthcare Stocks: Senseonics Holdings (SENS), Teladoc (TDOC)
Barclays
$118.88
Hold
13.01%
Upside
Reiterated
08/03/26
Barclays Sticks to Their Hold Rating for Teladoc (TDOC)
TD Cowen
$101.9
Hold
-3.13%
Downside
Reiterated
08/03/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Teladoc (NYSE: TDOC) and Karyopharm Therapeutics (NASDAQ: KPTI)
Citi
$186.81$127.37
Hold
21.08%
Upside
Reiterated
08/03/26
Teladoc price target lowered to $7.50 from $11 at CitiTeladoc price target lowered to $7.50 from $11 at Citi
Jefferies
$152.84$135.86
Hold
29.16%
Upside
Reiterated
07/30/26
Teladoc price target lowered to $8 from $9 at JefferiesTeladoc price target lowered to $8 from $9 at Jefferies
Stifel Nicolaus Analyst forecast on MX:TDOC
Stifel Nicolaus
Stifel Nicolaus
$93.4
Hold
-11.20%
Downside
Reiterated
07/30/26
Teladoc (TDOC) Receives a Hold from Stifel Nicolaus
Evercore ISI
$169.83$127.37
Hold
21.08%
Upside
Reiterated
07/30/26
Teladoc price target lowered to $7.50 from $10 at Evercore ISITeladoc price target lowered to $7.50 from $10 at Evercore ISI
Wells Fargo Analyst forecast on MX:TDOC
Wells Fargo
Wells Fargo
$101.9
Hold
-3.13%
Downside
Reiterated
07/30/26
Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC) and GE Healthcare Technologies Inc (NASDAQ: GEHC)
Needham
Hold
Reiterated
07/30/26
Teladoc: Mixed Business Performance and BetterHelp Growth Uncertainty Keep Ryan MacDonald at Hold
Cantor Fitzgerald Analyst forecast on MX:TDOC
Cantor Fitzgerald
Cantor Fitzgerald
$169.83
Buy
61.45%
Upside
Reiterated
07/29/26
Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), Teladoc (TDOC)
William Blair Analyst forecast on MX:TDOC
William Blair
William Blair
Hold
Reiterated
07/29/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Teladoc (NYSE: TDOC) and Boston Scientific (NYSE: BSX)
BMO Capital Analyst forecast on MX:TDOC
BMO Capital
BMO Capital
$84.91$118.88
Hold
13.01%
Upside
Assigned
07/29/26
Teladoc (TDOC) Receives a Hold from BMO Capital
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings
HITIHigh Tide
JAZZJazz Pharmaceuticals
OMCLOmnicell
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Teladoc

3 Months
Richard CloseCanaccord Genuity
Success Rate
23/46 ratings generated profit
50%
Average Return
-1.25%
Copying Richard Close's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -1.25% per trade.
1 Year
George HillDeutsche Bank
Success Rate
10/21 ratings generated profit
48%
Average Return
+15.18%
Copying George Hill's trades and holding each position for 1 Year would result in 47.62% of your transactions generating a profit, with an average return of +15.18% per trade.
2 Years
George HillDeutsche Bank
Success Rate
11/21 ratings generated profit
52%
Average Return
+37.03%
Copying George Hill's trades and holding each position for 2 Years would result in 52.38% of your transactions generating a profit, with an average return of +37.03% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TDOC Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
3
2
2
4
4
Buy
6
3
6
5
5
Hold
21
17
17
17
17
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
30
22
25
26
26
In the current month, TDOC has received 9 Buy Ratings, 17 Hold Ratings, and 0 Sell Ratings. TDOC average Analyst price target in the past 3 months is 130.20.
Each month's total comprises the sum of three months' worth of ratings.

TDOC Financial Forecast

TDOC Earnings Forecast

Next quarter’s earnings estimate for TDOC is -$3.69 with a range of -$4.37 to -$2.89. The previous quarter’s EPS was -$3.57. TDOC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year TDOC has Performed in-line its overall industry.
Next quarter’s earnings estimate for TDOC is -$3.69 with a range of -$4.37 to -$2.89. The previous quarter’s EPS was -$3.57. TDOC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year TDOC has Performed in-line its overall industry.

TDOC Sales Forecast

Next quarter’s sales forecast for TDOC is $10.04B with a range of $9.72B to $10.64B. The previous quarter’s sales results were $10.32B. TDOC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year TDOC has Performed in-line its overall industry.
Next quarter’s sales forecast for TDOC is $10.04B with a range of $9.72B to $10.64B. The previous quarter’s sales results were $10.32B. TDOC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year TDOC has Performed in-line its overall industry.

TDOC Stock Forecast FAQ

What is MX:TDOC’s average 12-month price target, according to analysts?
Based on analyst ratings, Teladoc’s 12-month average price target is 130.20.
    What is MX:TDOC’s upside potential, based on the analysts’ average price target?
    Teladoc has 23.78% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Teladoc a Buy, Sell or Hold?
          Teladoc has a consensus rating of Hold, which is based on 4 buy ratings, 12 hold ratings and 0 sell ratings.
            What is Teladoc’s share price target?
            The average share price target for Teladoc is 130.20. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $178.32 ,and the lowest forecast is $93.40. The average share price target represents 23.78% Increase from the current price of $105.19.
              What do analysts say about Teladoc?
              Teladoc’s analyst rating consensus is a Hold. This is based on the ratings of 16 Wall Streets Analysts.
                How can I buy shares of Teladoc?
                To buy shares of MX:TDOC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.